Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Perioperative flurbiprofen axetil in elective radical surgery for colon cancer
ChiCTR1900021426Phase 4Not yet recruiting
- Sponsor
- The Affiliated Hospital of Xuzhou Medical University
- Start
- Jan 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, single-arm trial of flurbiprofen axetil in colon cancer, sponsored by The Affiliated Hospital of Xuzhou Medical University. Primary endpoint: Changes in perioperative immune-related cells. Planned start Jan 2019; status: not yet recruiting.
02
Drugs
flurbiprofen axetil
03
Conditions
colon cancer
Beyond the preview
Go deeper on ChiCTR1900021426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR1900021426.